Mr. Speaker, my own sister had C. difficile and was at death's door at one time. She needed an experimental drug that cost $5,500 per dose. She was fortunate that the drug company gave her special access to it, but it could have gone the other way, so I absolutely agree with my colleague.
I want to take the opportunity just to say one more thing. Since I have been elected, this House has not taken advantage of the power of committees. One of the things we could do on a pharmacare program would be to call all the provincial health ministers before a parliamentary committee and get the input from the provinces that actually deliver health care. Some of the provinces have a drug plan. It would help us make sure we come up with a way that no one would fall through the cracks, one which was fiscally responsible and made sure every dollar was spent well and went to those people who needed the help. It would be an excellent way for a committee to work and bring about a plan that would be beneficial, would not encroach on provincial jurisdictions and at the same time, would make sure all Canadians have access to the drugs they need to stay healthy.